Related Experiment Videos
Combined modality therapy in high dose radioneurosurgery
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Positive feedback and angiogenesis in tumor growth control.
Bulletin of mathematical biology·1997
Host response in tumor growth and progression.
Invasion & metastasis·1996
A theoretical explanation of "concomitant resistance".
Bulletin of mathematical biology·1995
Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma: Survival and toxicity results of a multicenter randomized trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
From idealism to disillusionment: professional fulfillment, burnout, and retention across the multidisciplinary radiation oncology workforce.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Understanding retention in radiation oncology: quantitative findings from the retention survey by the ESTRO Early Career Committee.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Interpretable AI to predict anal cancer local failure at 3 years with the FFCD Anabase prospective multicentric cohort.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
External validation of a head & neck cancer outcome prediction model in radiotherapy patients: Evaluating generalisability in a geographically diverse population, with particular consideration of older patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Inequitable access to proton beam therapy in Europe: Efficiency, equity, and strategic infrastructure planning to 2030.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
TFAP2A enhances radioresistance of non-small cell lung cancer by transcriptionally activating BRCA1 : TFAP2A promotes NSCLC radioresistance.
Cellular oncology (Dordrecht, Netherlands)·2026